Global Large Molecule Drug Substance CDMO Market Size study, By Services (Contract Manufacturing, Contract Development), By Source (Mammalian, Microbial, Others), By End-user (Biotech Companies, CRO, Others), and Regional Forecasts 2022-2028

BIZ4983167
200 Pages
June 2022
Medical Devices

Download Sample Get Discount

Global Large Molecule Drug Substance CDMO Market is valued at approximately USD 10.7 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.6% over the forecast period 2022-2028. Large-molecule drugs are known as biologics or biopharmaceuticals are sophisticated therapeutics that are thousands of times larger in molecular size compared to their chemically-synthesized counterparts. A contract development and manufacturing company (CDMO) is a company across the pharmaceutical sector that offers manufacturing services and drug development. Various pharmaceutical companies collaborate with CDMOs as a way to outsource drug development and drug manufacturing. The growing prevalence of various infectious diseases, surging demand for novel therapeutics, as well as rising number of strategic initiatives by the market players like investment, product launch, and many others are bolstering the market demand across the globe. For instance, in June 2020, FUJIFILM Corp. intended to invest nearly USD 778 billion for their FUJIFILM Diosynth Biotechnologies’ Denmark site, CDMO for advanced therapies and biologics. This investment supports Denmark's site’s existing drug substance manufacturing capability by double fold. Consequentially, growing initiatives by the market players are augmenting the market growth in the near future. However, several compliance issues are associated with outsourcing, and the imposition of regulatory and legal compliance impedes the growth of the market over the forecast period of 2022-2028. Also, the increasing research and development investments and growth of the biopharmaceutical sector are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Large Molecule Drug Substance CDMO Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the heavy R&D investments, and the presence of various prominent market players. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as availability of a low-cost and skilled workforce as well as presence of favorable regulatory scenario would create lucrative growth prospects for the Large Molecule Drug Substance CDMO Market across the Asia-Pacific region.

Major market players included in this report are:

Eurofins Scientific

WuXi Biologics

Samsung Biologics

Catalent, Inc.

Cambrex Corp.

AGC Biologics

Recipharm AB (publ)

Siegfried Holding AG

LabCorp Drug Development

FUJIFILM Diosynth Biotechnologies

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Services:

Contract Manufacturing

Contract Development

By Source:

Mammalian

Microbial

Others

By End-user:

Biotech Companies

CRO

Others

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020

Base year – 2021

Forecast period – 2022 to 2028

Target Audience of the Global Large Molecule Drug Substance CDMO Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)

1.2.1. Large Molecule Drug Substance CDMO Market, by Region, 2020-2028 (USD Billion)

1.2.2. Large Molecule Drug Substance CDMO Market, by Services, 2020-2028 (USD Billion)

1.2.3. Large Molecule Drug Substance CDMO Market, by Source, 2020-2028 (USD Billion)

1.2.4. Large Molecule Drug Substance CDMO Market, by End-user, 2020-2028 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Large Molecule Drug Substance CDMO Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Large Molecule Drug Substance CDMO Market Dynamics

3.1. Large Molecule Drug Substance CDMO Market Impact Analysis (2020-2028)

3.1.1. Market Drivers

3.1.1.1. Growing prevalence of various infectious diseases

3.1.1.2. Surging demand for novel therapeutics

3.1.2. Market Challenges

3.1.2.1. Several compliance issues are associated with outsourcing

3.1.2.2. Imposition of regulatory and legal compliance

3.1.3. Market Opportunities

3.1.3.1. Increasing research and development investments

3.1.3.2. Growth of the biopharmaceutical sector

Chapter 4. Global Large Molecule Drug Substance CDMO Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Large Molecule Drug Substance CDMO Market, by Services

6.1. Market Snapshot

6.2. Global Large Molecule Drug Substance CDMO Market by Services, Performance - Potential Analysis

6.3. Global Large Molecule Drug Substance CDMO Market Estimates & Forecasts by Services, 2018-2028 (USD Billion)

6.4. Large Molecule Drug Substance CDMO Market, Sub Segment Analysis

6.4.1. Contract Manufacturing

6.4.2. Contract Development

Chapter 7. Global Large Molecule Drug Substance CDMO Market, by Source

7.1. Market Snapshot

7.2. Global Large Molecule Drug Substance CDMO Market by Source, Performance – Potential Analysis

7.3. Global Large Molecule Drug Substance CDMO Market Estimates & Forecasts by Source, 2018-2028 (USD Billion)

7.4. Large Molecule Drug Substance CDMO Market, Sub Segment Analysis

7.4.1. Mammalian

7.4.2. Microbial

7.4.3. Others

Chapter 8. Global Large Molecule Drug Substance CDMO Market, by End-user

8.1. Market Snapshot

8.2. Global Large Molecule Drug Substance CDMO Market by End-user, Performance - Potential Analysis

8.3. Global Large Molecule Drug Substance CDMO Market Estimates & Forecasts by End-user 2018-2028 (USD Billion)

8.4. Large Molecule Drug Substance CDMO Market, Sub Segment Analysis

8.4.1. Biotech Companies

8.4.2. CRO

8.4.3. Others

Chapter 9. Global Large Molecule Drug Substance CDMO Market, Regional Analysis

9.1. Large Molecule Drug Substance CDMO Market, Regional Market Snapshot

9.2. North America Large Molecule Drug Substance CDMO Market

9.2.1. U.S. Large Molecule Drug Substance CDMO Market

9.2.1.1. Services breakdown estimates & forecasts, 2018-2028

9.2.1.2. Source breakdown estimates & forecasts, 2018-2028

9.2.1.3. End-user breakdown estimates & forecasts, 2018-2028

9.2.2. Canada Large Molecule Drug Substance CDMO Market

9.3. Europe Large Molecule Drug Substance CDMO Market Snapshot

9.3.1. U.K. Large Molecule Drug Substance CDMO Market

9.3.2. Germany Large Molecule Drug Substance CDMO Market

9.3.3. France Large Molecule Drug Substance CDMO Market

9.3.4. Spain Large Molecule Drug Substance CDMO Market

9.3.5. Italy Large Molecule Drug Substance CDMO Market

9.3.6. Rest of Europe Large Molecule Drug Substance CDMO Market

9.4. Asia-Pacific Large Molecule Drug Substance CDMO Market Snapshot

9.4.1. China Large Molecule Drug Substance CDMO Market

9.4.2. India Large Molecule Drug Substance CDMO Market

9.4.3. Japan Large Molecule Drug Substance CDMO Market

9.4.4. Australia Large Molecule Drug Substance CDMO Market

9.4.5. South Korea Large Molecule Drug Substance CDMO Market

9.4.6. Rest of Asia Pacific Large Molecule Drug Substance CDMO Market

9.5. Latin America Large Molecule Drug Substance CDMO Market Snapshot

9.5.1. Brazil Large Molecule Drug Substance CDMO Market

9.5.2. Mexico Large Molecule Drug Substance CDMO Market

9.6. Rest of The World Large Molecule Drug Substance CDMO Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. Eurofins Scientific

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. WuXi Biologics

10.2.3. Samsung Biologics

10.2.4. Catalent, Inc.

10.2.5. Cambrex Corp.

10.2.6. AGC Biologics

10.2.7. Recipharm AB (publ)

10.2.8. Siegfried Holding AG

10.2.9. LabCorp Drug Development

10.2.10. FUJIFILM Diosynth Biotechnologies

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. Global Large Molecule Drug Substance CDMO Market, report scope

TABLE 2. Global Large Molecule Drug Substance CDMO Market estimates & forecasts by Region 2018-2028 (USD Billion)

TABLE 3. Global Large Molecule Drug Substance CDMO Market estimates & forecasts by Services 2018-2028 (USD Billion)

TABLE 4. Global Large Molecule Drug Substance CDMO Market estimates & forecasts by Source 2018-2028 (USD Billion)

TABLE 5. Global Large Molecule Drug Substance CDMO Market estimates & forecasts by End-user 2018-2028 (USD Billion)

TABLE 6. Global Large Molecule Drug Substance CDMO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 7. Global Large Molecule Drug Substance CDMO Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 8. Global Large Molecule Drug Substance CDMO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 9. Global Large Molecule Drug Substance CDMO Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 10. Global Large Molecule Drug Substance CDMO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 11. Global Large Molecule Drug Substance CDMO Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 12. Global Large Molecule Drug Substance CDMO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 13. Global Large Molecule Drug Substance CDMO Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 14. Global Large Molecule Drug Substance CDMO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 15. Global Large Molecule Drug Substance CDMO Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 16. U.S. Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 17. U.S. Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 18. U.S. Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 19. Canada Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 20. Canada Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 21. Canada Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 22. UK Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 23. UK Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 24. UK Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 25. Germany Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 26. Germany Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 27. Germany Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 28. RoE Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 29. RoE Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 30. RoE Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 31. China Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 32. China Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 33. China Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 34. India Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 35. India Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 36. India Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 37. Japan Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 38. Japan Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 39. Japan Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 40. RoAPAC Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 41. RoAPAC Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 42. RoAPAC Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 43. Brazil Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 44. Brazil Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 45. Brazil Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 46. Mexico Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 47. Mexico Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 48. Mexico Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 49. RoLA Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 50. RoLA Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 51. RoLA Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 52. Row Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 53. Row Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 54. Row Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 55. List of secondary sources, used in the study of global Large Molecule Drug Substance CDMO Market

TABLE 56. List of primary sources, used in the study of global Large Molecule Drug Substance CDMO Market

TABLE 57. Years considered for the study

TABLE 58. Exchange rates considered

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Global Large Molecule Drug Substance CDMO Market Size study, By Services (Contract Manufacturing, Contract Development), By Source (Mammalian, Microbial, Others), By End-user (Biotech Companies, CRO, Others), and Regional Forecasts 2022-2028

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara